← Eichor
Study identifier: NCT07033494 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

A Clinical Study of MK-2214 in People With Early Alzheimer's Disease (MK-2214-004)

Condition: Early Alzheimer's Disease  ·  Sponsor: Merck Sharp & Dohme LLC

PhasePhase 2
Planned participants340
Who can joinAll sexes, 50 Years to 85 Years
Healthy volunteersNo

About this study

Researchers want to know if the study treatment called MK-2214 works to slow certain changes in the brains of people with Alzheimer's disease (AD). AD is a type of dementia that can cause loss of memory, communication (such as speech), and decision-making skills. It can limit a person's ability to do daily tasks. MK-2214 is a study treatment designed to slow down AD. The goals of the study are to learn: * If MK-2214 slows the spread of tau in the brain compared to placebo. Tau is a protein that accumulates in AD \& damages brain cells. A placebo looks like the study treatment but has no study treatment in it. Using a placebo helps researchers better understand the effects of a study treatment. * About the safety of MK-2214 and if people tolerate it

This description comes directly from the study's public registry record.

Talk to the study team

Toll Free Number  ·  1-888-577-8839  ·  Trialsites@msd.com

Always discuss trial participation with your own doctor first.

Locations (79)

Irvine Clinical Research ( Site 1041)Irvine, California, United StatesRecruiting
Healthy Brain Clinic ( Site 1005)Long Beach, California, United StatesRecruiting
Inglewood Clinical ( Site 1062)Los Angeles, California, United StatesRecruiting
Anderson Clinical Research ( Site 1024)Redlands, California, United StatesRecruiting
UCSF Memory and Aging Center ( Site 1031)San Francisco, California, United StatesRecruiting
Syrentis Clinical Research ( Site 1001)Santa Ana, California, United StatesRecruiting
Yale University, Alzheimer's Disease Research Unit ( Site 1059)New Haven, Connecticut, United StatesRecruiting
JEM Research Institute ( Site 1046)Atlantis, Florida, United StatesRecruiting
Neuropsychiatric Research Center of Southwest Florida ( Site 1003)Fort Myers, Florida, United StatesRecruiting
K2 Medical Research ( Site 1047)Maitland, Florida, United StatesRecruiting
ClinCloud LLC ( Site 1039)Melbourne, Florida, United StatesRecruiting
Indago Research and Health Center Inc ( Site 1044)Miami Lakes, Florida, United StatesRecruiting

+ 67 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07033494